Professor Jim Smith, now Professor of Pharmacy Practice and Policy at the University of Sunderland, will also highlight several other controversial issues that surround the pharmaceutical sector and its practice.
Prof Smith was appointed England’s Chief Pharmaceutical Officer in 2001 and was in charge of implementing the Government's "Vision for Pharmacy" programme.
In his inaugural lecture at the university on Thursday, Prof Smith will explain why millions are being wasted on prescribed drugs that people are not using.
He will argue that of the £11bn spent each year on prescription drugs a substantial proportion of that is wasted through non-compliance, often impairing the health of those people for who the drugs are meant.
Prof Smith says: “There is good evidence that people accumulate large quantities of drugs but don’t use them, wasting money that the NHS can ill afford.
“There is also evidence that non-compliance it is linked to socio economic status – which has connotations for places like Sunderland – widening the health gap.
“Every Primary Care Trust is struggling with the costs of providing health care. However, so many of these medicines are not being taken, which is leading to further health problems
“There is evidence for example that some heart attack victims, who may be prescribed up to four drugs, do not take them properly and puts them at greater risk of a second heart attack.
“It’s a major problem. Fifteen per cent of NHS spending is on prescribed drugs.
“Many people, ultimately almost all of us, rely on medicines for their wellbeing. They can be life-enhancing and, for many people, lifesaving.
“Modern medicines are the product of an unprecedented scientific, clinical and industrial enterprise in which Britain is a world leader. They are contributing significantly to the increases in life expectancy and quality of life now being seen in this country. But our attitudes to medicines are ambivalent.
“We distrust the corporations that have, so successfully, developed new medicines. Governments laud the economic success of the industry but are sometimes reluctant to meet the cost of new drugs.
“The public, influenced at times by the news media, call for government bans in response to ‘drug scares’ but, paradoxically, also press for new drugs to be introduced across the NHS before clinical and economic evaluations are complete.”
Prof Smith’s lecture will explore these issues and argue for a mature and informed approach to the medicines we take.
He has worked as a community, industrial and hospital pharmacist and has held senior posts in health authorities in the North of England and in Central Government.
He has held consultancies with a number of pharmaceutical companies and with the World Health Organisation. In 2006 he was admitted as a fellow of the Faculty of Public Health of the Royal Colleges of Physicians of the United Kingdom.
Tony Kerr | alfa
Closing the carbon loop
08.12.2016 | University of Pittsburgh
Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences